FDA Alerts
FDA Drug Safety Communication: Reclast
The U.S. Food and Drug Administration (FDA) has approved an update to the drug label for Reclast ( zoledronic acid) to better inform healthcare professionals and patients of the risk of kidney (renal) failure.
FDA Drug Safety Communication: Celexa
The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and patients that the antidepressant Celexa ( citalopram hydrobromide ; also marketed as generics) should no longer be used at doses greater than 40 mg per day because it can cause abnormal changes in the electrical activity of the heart. Studies did not show a benefit in the treatment of depression at doses higher than 40 mg per day.
FDA Drug Safety Communication: Celexa
The U.S. Food and Drug Administration (FDA) is informing healthcare professionals and patients that the antidepressant Celexa ( citalopram hydrobromide ; also marketed as generics) should no longer be used at doses greater than 40 mg per day because it can cause abnormal changes in the electrical activity of the heart. Studies did not show a benefit in the treatment of depression at doses higher than 40 mg per day.
Previously, the citalopram drug label stated that certain patients may require a dose of 60 mg per day.
Facts about Celexa ( citalopram hydrobromide )
Is in a cla...
Reducing Fever in Children: Safe Use of Acetaminophen
You’re in the drug store, looking for a fever-reducing medicine for your children. They range in age from 6 months to 7 years, and you want to buy one product you can use for all of them.
FDA Drug Safety Communication: Diflucan
The U.S. Food and Drug Administration (FDA) is informing the public that chronic, high doses (400-800 mg/day) of the antifungal drug Diflucan ( fluconazole ) may be associated with a rare and distinct set of birth defects in infants whose mothers were treated with the drug during the first trimester of pregnancy.
FDA: Unapproved Emergency Birth Control May Be Ineffective, Unsafe
The U.S. Food and Drug Administration (FDA) is warning U.S. consumers not to use the emergency birth control medicine labeled as Evital . These products may be counterfeit versions of the “morning after pill” and may not be safe or effective in preventing pregnancy.
Evital has not been approved by the FDA for use in the United States.
This potentially ineffective and suspect counterfeit emergency birth control may also be in distribution in some Hispanic communities in the United States.
The packaging label of the potentially ineffective and suspect counterfeit version says, ...
Florida Firm Recalls Imported Beef Products Due To Potential Animal Drug Contaminant
Northwestern Meat, Inc., a Miami, Fla. firm, is recalling approximately 6,240 pounds of frozen boneless beef products imported from Honduras that may contain the animal drug Ivermectin , the U.S. Department of Agriculture’s Food Safety and Inspection Service ( FSIS ) announced today.
Tri State Beef Recall Due To E. Coli Risk
Tri State Beef, a Cincinnati, Ohio, establishment, is recalling approximately 228,596 pounds of beef products that may be contaminated with E. coli O157 : H7 , the U.S. Department of Agriculture’s Food Safety and Inspection Service ( FSIS ) announced today.
The following product is subject to recall:
Combo bins of "TRI-STATE BEEF CO., INC BONELESS BEEF."
Each bin bears the establishment number "EST. 1750" inside the USDA mark of inspection. The products subject to recall were produced between July 19, 2011 and July 22, 2011, and sold to federally-inspected establishments for ...
FDA Drug Safety Communication: Methylene blue (UPDATE)
The U.S. Food and Drug Administration (FDA) has received reports of serious central nervous system (CNS) reactions when the drug methylene blue is given to patients taking psychiatric medications that work through the serotonin system of the brain ( serotonergic psychiatric medications).
Foodborne Outbreak Potentially Associated With Papaya
The FDA is warning consumers not to eat papayas from Agromod Produce, Inc., a distributor in McAllen,Texas.